Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Diabetes Obes Metab. 2022 Nov 21;25(3):688–699. doi: 10.1111/dom.14911

Table 2:

Three-Month Pre-COVID-19 Diet Period 1 Intervention Effects—Overall and by Randomized Diet Assignment

Primary Outcomes
All (n=38) Diet Assignment (Low carbohydrate as P-value Reference)
Low carb (n=16) Look AHEAD (n=12) Mediterranean (n=10) p-value
 Weight (kg)
  Baseline 87.4 ± 12.9 87.2 ± 10.8 90.5 ± 16.5 84.1 ± 11.5 0.53
  ~3-months 85.4 ± 12.7 84.8 ± 11.8 89.2 ± 15.5 81.7 ± 10.2 0.39
   ~3-month change −2.0 (−3.0, −1.1), p<0.0001 −2.4 (−3.9, −0.93) −1.3 (−3.4, 0.82) −2.4 (−4.3, −0.52) 0.55
 HbA1c (%)
  Baseline 7.9 ± 1.5 7.3 ± 1.6 8.3 ± 1.3 8.3 ± 1.4 0.14
  ~3-months 7.8 ± 1.5 7.3 ± 1.6 7.7 ± 1.0 8.6 ± 1.7 0.09
  ~3-month percentage point change −0.13 (−0.39, 0.12), p=0.29 −0.04 (−0.25, 0.17) −0.65 (−1.1, −0.18), p=0.027 0.34 (−0.34, 1.0), p=0.18 0.006
 HbA1c (mmol/mol)
  Baseline 63 ± 16.4 56 ± 17.5 67 ± 14.2 67 ± 15.3 0.14
  ~3-months 62 ± 16.4 56 ± 17.5 61 ± 10.9 70 ± 18.6 0.09
  ~3-month change −1.4 (−4.3, 1.3), p=0.29 −0.4 (−2.7, 1.9) −7.1 (−12.0, −2.0), p=0.027 3.7 (−3.7, 10.9), p=0.18 0.006
All (n=28) Low carb (n=12) Look AHEAD (n=8) Mediterranean (n=8) p-value
 % Time below range (<70 mg/dL)
  Baseline 5.0 (1.9, 9.8) 6.0 (2.9, 12.3) 4.3 (1.6, 8.2) 3.5 (0.73, 6.9) 0.29
  ~3-months 5.3 (2.2, 9.8) 9.1 (4.5, 11.4) 3.1 (1.5, 7.6) 3.3 (0.43, 6.5) 0.04
  ~3-month percentage point change 0.42 (−1.7, 2.6), p=0.69 1.3 (−2.1, 4.6) 0.23 (−3.9, 4.4) −0.64 (4.8, 3.5) 0.76
Secondary outcomes
All (n=38) Low carb (n=16) Look AHEAD (n=12) Mediterranean (n=10) p-value
 Body fat (%)
  Baseline 42.2 (34.7, 45.2) 42.1 (29.4, 45.2) 42.8 (37.7, 45.3) 40.7 (34.8, 45.2) 0.83
  ~3-months 40.6 (33.8, 44.7) 40.5 (27.9, 44.2) 43.7 (37.3, 45.5) 40.1 (35.9, 43.2) 0.52
  ~3-month percentage point change −0.53 (−1.0, −0.03), p=0.04 −0.87 (−1.7, −0.05) −0.058 (−0.83, 0.72) −0.57 (−1.9, 0.75) 0.39
 Body fat (kg)
  Baseline 34.4 ± 9.8 32.6 ± 10.6 37.1 ± 9.6 34.1 ± 8.8 0.49
  ~3-months 33.3 ± 10.0 31.0 ± 11.2 36.7 ± 9.9 32.8 ± 7.6 0.33
  ~3-month change −1.1 (−1.9, −0.40), p=0.003 −1.6 (−2.8, −0.38) −0.36 (−1.6, 0.83), p=0.76 −1.3 (−3.1, 0.44), p=0.15 0.34
All (n=28) Low carb (n=12) Look AHEAD (n=8) Mediterranean (n=8) p-value
 % Time in range (70–180 mg/dL)
  Baseline 52.6 ± 26.0 55.8 ± 25.5 58.2 ± 24.2 42.3 ± 28.8 0.42
  ~3-months 54.8 ± 22.9 58.0 ± 24.8 63.6 ± 17.0 41.4 ± 21.1 0.12
  ~3-month percentage point change 2.2 (−3.4, 7.8), p=0.43 2.1 (−6.7, 11.0) 5.4 (−8.7, 19.6) −0.88 (−12.6, 10.8) 0.70
 % Time below range (<54 mg/dL)
  Baseline 0.82 (0.19, 2.8) 1.6 (0.73, 3.1) 0.21 (0.04, 1.9) 0.71 (0.0, 2.9) 0.63
  ~3-months 1.2 (0.19, 3.3) 1.6 (0.63, 3.8) 0.37 (0.0, 3.7) 1.2 (0.0, 2.9) 0.45
  ~3-month percentage point change 0.00 (−1.2, 1.5), p=0.68 0.67 (−1.1, 2.5) 0.57 (−1.6, 2.8) 0.18 (−2.0, 2.4) 0.93
Additional CGM indices
 % Time above range (181–250 mg/dL)
  Baseline 19.7 ± 8.7 18.7 ± 11.5 19.0 ± 5.2 21.8 ± 7.3 0.73
  ~3-months 21.3 ± 12.0 18.0 ± 11.8 17.1 ± 8.2 30.3 ± 11.7 0.03
  ~3-month percentage point change 0.32 (−2.9, 6.5), p=0.61 −0.53 (−7.4, 5.9) −1.1 (−2.9, 0.68) 6.6 (1.2, 13.8) 0.07
 % Time above range (>250 mg/dL)
  Baseline 9.0 (2.2, 4.3) 5.2 (0.19, 38.9) 8.3 (2.5, 19.7) 29.9 (4.7, 51.6) 0.28
  ~3-months 9.8 (2.5, 27.5) 7.1 (0.57, 18.9) 8.5 (4.3, 23.5) 22.8 (8.1, 35.5) 0.26
  ~3-month percentage point change −4.2 (−11.5, 3.2), p=0.25 −2.7 (−12.6, 7.2) −3.6 (−18.1, 10.9) −7.0 (−28.9, 14.9) 0.89
 CV (%)
   Baseline 37.3 ± 6.5 37.2 ± 6.8 38.2 ± 6.0 36.4 ± 7.3 0.69
  ~3-months 38.1 ± 6.9 37.6 ± 8.2 40.4 ± 6.6 36.4 ± 4.9 0.50
  ~3-month change 0.46 (−2.4, 3.1), p=0.67 0.27 (−1.9, 3.2) −0.14 (−2.8, 5.5) 1.8 (−3.0, 2.3) 0.99

Baseline values are mean ±SD or median (IQR). Change values are mean (95% confidence interval) or median (IQR). Within-group p-values are from paired t tests for normally distributed variables or the Wilcoxon signed rank test for non-normally distributed variables.

P-values for diet difference in the rightmost column were calculated using ANOVA for normally distributed variables or the Kruskal Wallis test for non-normally distributed variables.

Abbreviations: CV—coefficient of variation; Low carb—Low carbohydrate; mg/dL—milligrams per deciliter; HbA1c—hemoglobin A1c.